EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Liver cirrhosis and complications of chronic fascioliasis in childhood. A case report

Giovanni Callizaya-Macedo, José Miguel Cussi Romero, Jhossmar Cristians Auza-Santivañez, José Antonio Lagos Monasterios, Angel Simon Chuquimia Calderon, María Angela Murillo Alcázar, Daniela Nicole Pacheco de la Torre, Freddy Ednildon Bautista-Vanegas

SAP Primary Care · 2026-07-31 · 2 · 147

DOI: 10.62486/pc2026147 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Fascioliasis, a zoonosis caused by Fasciola hepatica, is a significant public health problem in the Bolivian highlands, especially among children. Although the disease is usually benign, in undiagnosed cases, it can progress to severe forms such as liver cirrhosis. Case report: We describe a 5-year-old patient from an endemic area who presented with abdominal distension, hepatomegaly, ascites, and edema. Laboratory tests revealed severe hypoalbuminemia, coagulopathy, eosinophilia, and a cholestatic pattern. Imaging confirmed chronic liver disease with portal hypertension. The patient’s condition deteriorated, leading to neurological complications and death associated with sepsis and malnutrition. Discussion: This case demonstrates a consistent pathophysiological progression from chronic parasitic infection to liver fibrosis and cirrhosis. It highlights the diagnostic challenges in advanced stages and the reliance on clinical and epidemiological criteria in settings with limited access to confirmatory tests. It also reveals shortcomings in early diagnosis and timely access to treatment. Conclusions: Chronic fascioliasis caused by Fasciola hepatica can progress to liver cirrhosis in children, although this is rare, confirming its potential as a cause of severe chronic liver disease. In Bolivia, it is not a rare disease but rather an invisible one. Access to early diagnosis remains limited. Controlling this disease requires an intersectoral approach involving health, education, and basic sanitation. Fascioliasis should be considered a priority differential diagnosis for liver disease in childhood.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →